Jessica Bond is an associate attorney with the Plato Law Firm and was selected as a Michigan Rising Star in the area of Construction Litigation by the Super Lawyers publication in 2018 and 2019. She is a member of the State Bar of Michigan and admitted to practice in the U.S. District Court, Eastern District of Michigan. Her practice focuses on insurance defense, construction litigation, municipal law, and advising closely held businesses on various matters.
She has successfully defended a number of Michigan construction companies and municipalities from personal injury and property damage claims as well as prosecuted and defended derivative subrogation and indemnity claims, following from those incidents. She regularly litigates disputes between company members and corporate shareholders and successfully negotiated and won approval for a special land use application for an approximately one million-square-foot, mixed use industrial complex in Plymouth Township, Michigan. She also handles select contract, landlord-tenant, and employment matters.
Prior to joining The Plato Law Firm, Ms. Bond worked for a Detroit-area firm specializing in bankruptcy and commercial law matters, and before that with a firm specializing in land use and municipal law matters. She graduated magna cum laude from the University of Detroit Mercy School of Law where she served as the Law Review’s Executive Editor of Inside Articles and as a member of the Moot Court Board of Advocates. As a law student, she also achieved book awards for receiving the highest grade in Advanced Advocacy, Corporate Governance, Advising Entrepreneurs in Business, Federal Jurisdiction, Immigration Law Clinic, National Security Law, Payment Systems, and Remedies. She was also inducted into the Frank Murphy Honor Society, for graduating in the top 10% of her class.
Jessica regularly volunteers with and serves as the president of the Board of Directors for Camp Casey, a Michigan nonprofit organization that provides horse day camps and other programs for children undergoing treatment for cancer, sickle cell disease, or aplastic anemia.